Found: 5
Select item for more details and to access through your institution.
Carmustine (BCNU) plus Teniposide (VM26) in Recurrent Malignant Glioma.
- Published in:
- Oncology, 2014, v. 86, n. 5/6, p. 369, doi. 10.1159/000360295
- By:
- Publication type:
- Article
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 8, p. 1581, doi. 10.1007/s00432-018-2671-z
- By:
- Publication type:
- Article
The earlier the better? Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 8, p. 1825, doi. 10.1007/s00432-016-2187-3
- By:
- Publication type:
- Article
Phase I trial of dovitinib (TKI258) in recurrent glioblastoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 7, p. 1581, doi. 10.1007/s00432-016-2161-0
- By:
- Publication type:
- Article
<sup>18</sup>F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case report.
- Published in:
- 2016
- By:
- Publication type:
- Case Study